The trademark application Pantalandir was filed by SyneuRx International (Taiwan), a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). The application was published for oppositions on April 29, 2020, and it was registered by office on August 6, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Acids for pharmaceutical purposes
Antibiotics
Antiviral antibiotics
Cachets for pharmaceutical purposes
Cachou for pharmaceutical purposes
Candy, medicated
Candy for medical purposes
Capsules for medicines
Chemical preparations for pharmaceutical purposes
Chemical preparations for medical purposes
Chemical preparations for veterinary purposes
Chemical reagents for medical or veterinary purposes
Chemico-pharmaceutical preparations
Chewing gum for medical purposes
Dietetic foods adapted for medical purposes
Dietetic beverages adapted for medical purposes
Dietetic substances adapted for medical use
Drugs for medical purposes
Flour for pharmaceutical purposes
Meal for pharmaceutical purposes
Freeze-dried food adapted for medical purposes
Lyophilized food adapted for medical purposes
Germicides
Gum for medical purposes
Homogenized food adapted for medical purposes
Medicated animal feed
Medicated dentifrices
Medicinal infusions
Medicines for human purposes
Medicines for veterinary purposes
Preparations of microorganisms for medical or veterinary use
Nervines
Nutraceutical preparations for therapeutic or medical purposes
Nutritional supplements
Ointments for pharmaceutical purposes
Pastilles for pharmaceutical purposes
Lozenges for pharmaceutical purposes
Pectin for pharmaceutical purposes
Pharmaceutical preparations
Pharmaceuticals
Poultices
Pre-filled syringes for medical purposes
Salts for medical purposes
Sedatives
Tranquillizers
Suppositories
Syrups for pharmaceutical purposes
Tonics [medicines]
Inhalants
Compounds for treating correlated pulmonary syndromes
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension.
The mark was filed in class 42 with following description of goods:
Biological research
Clinical trials
Research and development of new products for others